Suspension systems in continuous viral vector production processes
Cell & Gene Therapy Insights 2020; 6(1), 123-126.
Published: 10 March 2020
Felipe Tapia is a chemical engineer with a PhD in bioprocess engineering carried out at the Max Planck Institute in Germany. He specializes in continuous virus production and is a co-Founder of ContiVir, a startup project that develops fully continuous processes of gene therapy viral vectors. ContiVir received a €1.1 million grant from the European Union, the German government and the Max Planck Society and its development is taking place at the Bioprocess Engineering Group of the Max Planck Institute in Magdeburg (Director: Prof. Udo Reichl).